December 20, 2023 Comments Off on New patent for Glaxo Grp drug ADVAIR HFA Posted in: Patent Added Annual Drug Patent Expirations for ADVAIR+HFA Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. There are…
The post New patent for Glaxo Grp drug ADVAIR HFA appeared first on DrugPatentWatc…
December 20, 2023 Comments Off on New patent for Astrazeneca Ab drug FARXIGA Posted in: Patent Added Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from three suppliers. There are sixteen patents…
The post New patent for Astrazeneca Ab drug FARXIGA appeared first on D…